Racial Differences in Adverse Events After Androgen Deprivation in Veterans With Prostate Cancer
JAMA Network Open · 2025
DOI: 10.1001/jamanetworkopen.2025.45705 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Network Open, 2025. Verfasst von Nadine A Friedrich und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Cedars-Sinai Medical Center, Los Angeles, California. Hauptthemen laut MEDLINE: Androgen Antagonists, Antineoplastic Agents, Hormonal, Cardiovascular Diseases, Prostatic Neoplasms. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Patientensicherheit
Abstract (Originalsprache)
Importance Androgen deprivation therapy (ADT) for prostate cancer (PC) has been linked to adverse events, such as cardiac events and osteoporosis. Whether these associations differ by race is unknown.
Objective
To assess the association between ADT and time to cardiovascular and bone-related adverse events across racial groups. Design, Setting, and Participants This retrospective, nationwide, population-based, cohort study used electronic health records from the Veterans Affairs Health Care System (VAHCS) database from January 2001 to December 2021, with follow-up until death or study end. Participants included veterans with PC. Patients undergoing bilateral orchiectomy, receiving gonadotropin-releasing hormone antagonists, or lacking data on race and ethnicity were excluded. Data analysis was performed from January to March 2023. Exposure Luteinizing hormone–releasing hormone agonists (leuprolide, goserelin, or triptorelin) use as a time-dependent variable and first-line systemic therapy. Main Outcomes and Measures The primary outcome was time to first cardiovascular event (myocardial infarction, stroke, coronary heart disease, congestive heart failure, or peripheral vascular disease). Secondary outcomes included osteoporosis, bone fracture, and a composite event (any of these). Cox models assessed the association between ADT as a time-dependent covariate and time-to-event across all patients by race.
Results
Among 790 916 veterans with PC (30 139 [4%] Hispanic; 145 267 non-Hispanic Black [18%]; 598 574 non-Hispanic White [76%]; and , 16 936 other races [2%]), ADT was associated with increased risk of cardiovascular events (hazard ratio [HR], 1.16; 95% CI, 1.15-1.17; P < .001), bone fractures (HR, 1.59; 95% CI, 1.55-1.62; P < .001), osteoporosis (HR, 2.73; 95% CI, 2.65-2.80; P < .001), and composite event (HR, 1.29; 95% CI, 1.27-1.30; P < .001). When stratified by race, ADT remained significantly associated with all outcomes among all races. Among Black patients, compared with White patients, the excess risk due to ADT was slightly lower for cardiovascular events (HR, 1.09 [95% CI, 1.06-1.17] vs 1.18 [95% CI, 1.16-1.19]) and bone fracture (HR, 1.35 [95% CI, 1.28-1.42] vs 1.65 [95% CI, 1.61-1.70]) but higher for osteoporosis (HR, 3.16 [95% CI, 2.95-3.38] vs 2.64 [95% CI, 2.56-2.73]). HRs for Hispanic patients and those of other races were very similar to those for White patients. Conclusions and Relevance In this cohort study of 790 916 veterans with PC, ADT was associated with increased cardiovascular and bone risks across all racial groups. Although excess risks differed slightly between Black and White patients, overall differences were small. These findings highlight the need for monitoring and mitigation strategies for patients receiving ADT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Urology, Cedars-Sinai Medical Center, Los Angeles, California.
- Department of Computational Biomedicine, Cedars-Sinai Medical Center, Los Angeles, California.
- Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California.
- Department of Surgery, Veterans Affairs Health Care System, Durham, North Carolina.
- Department of Cardiology, Cedars-Sinai Medical Center, Los Angeles, California.
Zitieren
APA
Friedrich, N. A., Janes, J. L., Parrish, J., De Hoedt, A. M., Josan, K., Tatonetti, N. P., & Freedland, S. J. (2025). Racial Differences in Adverse Events After Androgen Deprivation in Veterans With Prostate Cancer. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2025.45705
Vancouver
Friedrich NA, Janes JL, Parrish J, De Hoedt AM, Josan K, Tatonetti NP, et al. Racial Differences in Adverse Events After Androgen Deprivation in Veterans With Prostate Cancer. JAMA Network Open. 2025. doi:10.1001/jamanetworkopen.2025.45705
BibTeX
@article{Friedrich2025,
author = {Friedrich, Nadine A and Janes, Jessica L and Parrish, Joshua and De Hoedt, Amanda M and Josan, Kiranbir and Tatonetti, Nicholas P and Freedland, Stephen J},
title = {Racial Differences in Adverse Events After Androgen Deprivation in Veterans With Prostate Cancer},
journal = {JAMA Network Open},
year = {2025},
doi = {10.1001/jamanetworkopen.2025.45705}
}
EUVIMED